Mari Dallas, MD

    Mari H. Dallas, MD

    Assistant Member, St. Jude Faculty

    Departments

    Bone Marrow Transplantation & Cellular Therapy

    Contact Information

    Mari Dallas, MD
    Bone Marrow Transplantation & Cellular Therapy
    MS 321, Room D5062-B
    St. Jude Children's Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105-3678
    Email: mari.dallas@stjude.org
    Phone: (901) 595-6528
    FAX: (901) 595-6541

    Education

    MD – University of Pennsylvania School of Medicine (1999)


    Honors & Awards


    Research Interests


    Selected Publications

    Dallas MH, Triplett B, Shook DR, Hartford C, Srinivasan A, Laver J, Ware R, Leung W. Long Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease. Biol Blood Marrow Transplant Feb 14, 2013. doi:pii: S1083-8791(13)00082-7. 10.1016/j.bbmt.2013.02.010

    Shook DR, Triplett BM, Srinivasan A, Hartford C, Dallas MH, Pillai A, Laver J, Leung W. Successful Allogeneic Hematopoietic Cell. Engraftment after a Minimal Conditioning Regimen in Children with Relapsed or Refractory Solid Tumors. Biol Blood Marrow Transplant Oct 9;(12):00401-6, 2012.

    Triplett B, Wang C, Yang J, Dallas M, Hartford C, Howard V, Pillai A, Shook D, Srinivasan A, Laver J, Leung W, Effects of Conditioning Regimens and T Cell Depletion in Hematopoietic Cell Transplantation for Primary Immune Deficiency. Biol Blood Marrow Transplant Jul 27;(12):00303-5, 2010.

    Leung W, Pui CH, Coustan-Smith E, Yang J, Pei D, Gan K, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Shook D, Rubnitz JE, Sandlund JT, Jeha S, Inaba H, Ribeiro RC, Handgretinger R, Laver JH, Campana D. Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood April 19, 2012. doi: 10.1182/2012-02-409813

    Pillai A, Hartford C, Wang C, Pei D, Yang J, Srinivasan A, Triplett B, Dallas M, Leung W. Favorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia. Pediatr Transplant Sep;15(6):628-34, 2011.

    Leung W, Yang J, Campana D, Pei D, Gan K, Rubnitz J, Sandlund J, Ribeiro R, Srinivasan A, Hartford C, Triplett B, Dallas M, Pillai A, Pui C, High Success of Hematopoietic Cell Transplantation Regardless of Donor Source in Children with Very-High-Risk Leukemia. Blood Jul 14;118(2):223-30, 2011.

    Varnum-Finney B, Dallas M, Bernstein ID. Notch target Hes5 ensures appropriate Notch induced T vs. B-cell choices in the thymus. Blood 111(5): 2615-20, 2008.

    Dallas M, Martin P, Varnum-Finney B, Bernstein ID. Enhanced T cell reconstitution with Ex-vivo Expanded Hematopoietic Progenitors Using Notch Ligand Delta1. Blood 109(8): 3579-87, 2007. PMCID: PMC1852253

    Dallas M, Varnum-Finney B, Bernstein ID. Density of the Notch Ligand Delta1 Determines Generation of B and T Cell Precursors from Hematopoietic Stem Cells. J Exp Med 201(9): 1361-6, 2005. PMCID: PMC2213184

    Last updated March 2013